Marvin 08061016172D 16 15 0 0 0 0 999 V2000 3.8598 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1454 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4309 0.0295 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.7164 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0019 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2875 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4270 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1415 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8434 0.7439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8475 0.6128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4270 0.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8560 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5704 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2849 0.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9994 -0.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2849 0.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 3 9 1 6 0 0 0 3 10 1 0 0 0 0 7 11 1 0 0 0 0 8 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 14 16 1 0 0 0 0 M END > CHEBI:59958 > (3S,6E)-nerolidol > A (6E)-nerolidol in which the hydroxy group at positon 3 adopts an S-configuration. > 3 > (S-(E))-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (3S,6E)-Nerolidol; (3S,6E)-nerolidol > (3S,6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol > C15H26O > 222.36630 > 222.19837 > 0 > CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C > InChI=1S/C15H26O/c1-6-15(5,16)12-8-11-14(4)10-7-9-13(2)3/h6,9,11,16H,1,7-8,10,12H2,2-5H3/b14-11+/t15-/m1/s1 > FQTLCLSUCSAZDY-ATGUSINASA-N > 5248349 > 1119-38-6 > 1119-38-6 > C09704 > LMPR0103010005 > 10482672; 30607684; 33362256 $$$$